COVID-19 and ovarian cancer: Exploring alternatives to intravenous (IV) therapies

• The pandemic COVID-19 requires alternative methods and thinking to keep healthcare professionals and patients safe. • In COVID-19 hot spots, oral therapies may be viable alternatives to intravenous therapies for treatment of ovarian cancer. • Minimizing patient visits to hospitals and cancer clini...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Gynecol Oncol
Autors principals: Monk, Bradley J., Coleman, Robert L., Moore, Kathleen N., Herzog, Thomas J., Secord, Angeles Alvarez, Matulonis, Ursula A., Slomovitz, Brian M., Guntupalli, Saketh R., O'Malley, David M.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier Inc. 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7188656/
https://ncbi.nlm.nih.gov/pubmed/32370991
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2020.04.703
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars